Moebius Medical Company

Moebius Medical Ltd. is an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis. The company was founded in 2008, and is based on a patent-protected technology that was licensed from the Hebrew University of Jerusalem, the Technion Institute and Hadassah Medical Center. The Company’s lead product, MM-II, is a patent-protected intraarticular biolubricant injection for treatment of mild to moderate symptomatic knee osteoarthritis (OA).
Technology: Health Care, Health Diagnostics, Medical
Industry: Personalized Medicine
Headquarters: Tel Aviv, Israel
Founded Date: 2008
Employees Number: 2 - 10
Funding Status: N/A

Visit Website
Register and Claim Ownership